Oxidative Stress in Patients Undergoing Modified Radical Mastectomy Under Sevoflurane compared to Total Intravenous Anesthesia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201604001579155

Enrollment

Registered

2016-04-11

Start date

2016-02-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Surgery Anaesthesia

Interventions

total intravenous group ¿TIVA group

sevoflurane group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients above the age of 18 years, ASA I-II undergoing modified radical mastectomy

Exclusion criteria

Exclusion criteria: Patients with renal dysfunction, hepatic dysfunction, cardiovascular diseases inflammatory diseases

Design outcomes

Primary

Measure	Time frame
serum nitric oxide	—

Secondary

Measure	Time frame
total antioxidant;postoperative complications;hospital stay	—

Countries

Egypt

Contacts

Public ContactAhmed Essam Eldin

lecturer of anesthesiology and surgical intensive care, Tanta university

madamada6@gmail.com00201001802978

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026